<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; Changers</title>
	<atom:link href="http://www.tapanray.in/tag/changers/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>The Game Changers in 2012 and A Crystal Gazing into 2013</title>
		<link>http://www.tapanray.in/the-game-changers-in-2012-and-a-crystal-gazing-into-2013/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=the-game-changers-in-2012-and-a-crystal-gazing-into-2013</link>
		<comments>http://www.tapanray.in/the-game-changers-in-2012-and-a-crystal-gazing-into-2013/#comments</comments>
		<pubDate>Mon, 31 Dec 2012 00:00:26 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Blog]]></category>
		<category><![CDATA[Pharma]]></category>
		<category><![CDATA[2012]]></category>
		<category><![CDATA[2013]]></category>
		<category><![CDATA[Access]]></category>
		<category><![CDATA[Bayer]]></category>
		<category><![CDATA[Changers]]></category>
		<category><![CDATA[CL]]></category>
		<category><![CDATA[Compulsory]]></category>
		<category><![CDATA[Crystal]]></category>
		<category><![CDATA[Drug]]></category>
		<category><![CDATA[Essential]]></category>
		<category><![CDATA[Game]]></category>
		<category><![CDATA[Gazing]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[IPR]]></category>
		<category><![CDATA[License]]></category>
		<category><![CDATA[Medicines]]></category>
		<category><![CDATA[Natco]]></category>
		<category><![CDATA[Nexavar]]></category>
		<category><![CDATA[NLEM2011]]></category>
		<category><![CDATA[NPPP 2012]]></category>
		<category><![CDATA[Patent]]></category>
		<category><![CDATA[Policy]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Tapan]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=1374</guid>
		<description><![CDATA[Wish You and Your Dear Ones Best of Health, Happiness, Success and Prosperity in The Brand New Year. Welcome 2013  The Global Pharmaceutical Industry (GPI), by and large, used to be considered as ‘recession-proof’ for various valid reasons. However, the &#8230; <a href="http://www.tapanray.in/the-game-changers-in-2012-and-a-crystal-gazing-into-2013/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/the-game-changers-in-2012-and-a-crystal-gazing-into-2013/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>India and China&#8230;Practical relevance of &#8216;Priority Watch List (PWL)&#8217; status in ‘Special 301 Reports’ of America&#8230;and the REAL ‘Game Changers’</title>
		<link>http://www.tapanray.in/india-and-china-practical-relevance-of-priority-watch-list-pwl-status-in-special-301-reports-of-america-and-the-real-game-changers/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=india-and-china-practical-relevance-of-priority-watch-list-pwl-status-in-special-301-reports-of-america-and-the-real-game-changers</link>
		<comments>http://www.tapanray.in/india-and-china-practical-relevance-of-priority-watch-list-pwl-status-in-special-301-reports-of-america-and-the-real-game-changers/#comments</comments>
		<pubDate>Mon, 10 May 2010 00:30:49 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[301]]></category>
		<category><![CDATA[America]]></category>
		<category><![CDATA[Changers]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[Game]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[infringement]]></category>
		<category><![CDATA[IP]]></category>
		<category><![CDATA[IPR]]></category>
		<category><![CDATA[List]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[Patent]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[practical]]></category>
		<category><![CDATA[Priority]]></category>
		<category><![CDATA[Protection]]></category>
		<category><![CDATA[PWL]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[RDP]]></category>
		<category><![CDATA[REAL]]></category>
		<category><![CDATA[Relevance]]></category>
		<category><![CDATA[Reports]]></category>
		<category><![CDATA[Special]]></category>
		<category><![CDATA[status]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Watch]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=430</guid>
		<description><![CDATA[Many stakeholders around the world believe that Intellectual Property Rights (IPR) environment in China is far better than what we have in India. Interestingly “2010 Special 301 Report” of the United States of America dated April 30, 2010, paints a &#8230; <a href="http://www.tapanray.in/india-and-china-practical-relevance-of-priority-watch-list-pwl-status-in-special-301-reports-of-america-and-the-real-game-changers/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/india-and-china-practical-relevance-of-priority-watch-list-pwl-status-in-special-301-reports-of-america-and-the-real-game-changers/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
